Medicinal Plants against Candida spp.
Subjects: Microbiology

The use of natural products to promote health is as old as human civilization. In recent years, the perception of natural products derived from plants as abundant sources of biologically active compounds has driven their exploitation towards the search for new chemical products that can lead to further pharmaceutical formulations. Candida fungi, being opportunistic pathogens, increase their virulence by acquiring resistance to conventional antimicrobials, triggering diseases, especially in immunosuppressed hosts. They are also pointed to as the main pathogens responsible for most fungal infections of the oral cavity. This increased resistance to conventional synthetic antimicrobials has driven the search for new molecules present in plant extracts, which have been widely explored as alternative agents in the prevention and treatment of infections.

  • Candida spp.
  • oral disease
  • oral biofilm
  • infections
  • medicinal plants
  • plant extracts
  • natural compounds
  • antibiofilm strategies

1. Introduction

Medicinal plants have been used for several centuries to treat a wide variety of ailments. In recent years, the investigation into molecules derived from these plants, which play a fundamental role in the resistance of various pathogens, has boosted the study of their antibacterial and/or antibiofilm properties [1,2,3]. Some plant compounds can interact with bacterial proteins and cell membrane structures, damaging them and reducing their fluidity, while inhibiting their nucleic acid synthesis and interfering with the energy metabolism of the microorganisms themselves [2,4,5]. Additionally, the study of the antibiofilm properties associated with these molecules has revealed that, in addition to their fungicidal/bactericidal effect, other underlying mechanisms can lead to biofilm suppression, namely, disturbances at the level of bacterial regulation mechanisms [6].
The biofilm is a more resistant form of microbial existence on solid surfaces and air–liquid interfaces in which microorganisms multiply in a matrix of self-produced extracellular polymeric substances (EPS) [7]. Its resistance is directly related to the natural survival characteristics of the microbial cells that live in these communities. The slower growth of cells associated with the biofilm, as opposed to free-living microbial cells, and the tight regulation of the cellular processes, stand out, and are mainly caused by the more restricted contact of the cells inside the biofilm with external nutrients. In addition, the presence of an EPS matrix that hinders the action of antimicrobials contributes even more to the resistance of biofilms, since this matrix acts as a diffusion barrier against small molecules [8,9].
Biofilms can be found in a variety of surfaces, both biotic and abiotic. Particularly in the oral cavity, biofilm can be found in the teeth and mucosal surfaces and are thought to consist of approximately 700 bacterial species, 100 fungal species, and some viruses [10]. Since these microorganisms coexist in the same environment, there is the possibility of interactions between different species, a factor that can make an oral infection more difficult to treat, creating an environment of protection and tolerance for microorganisms against conventional antimicrobial agents [11].
One of the main groups of microorganisms that can be found in the normal oral flora is the genus Candida, which is composed of dimorphic commensal yeast. Although Candida species are mainly nonpathogenic, when an imbalance in the oral microbiome occurs, they are the main pathogens responsible for the occurrence of fungal infections in the oral cavity [12]. One of the key virulence factors associated with these microorganisms is their ability to adhere to oral surfaces and form biofilms, which function as a reservoir for this type of fungi, both in teeth and mucosal surfaces [13,14]. Several factors contribute to the unbalanced colonization and biofilm formation in the oral cavity by Candida spp., namely, low salivary flow, low pH and poor oral hygiene among others [15]. As an opportunistic pathogen, this yeast can also cause disease when the host’s immune system is debilitated by the appearance of pathologies such as diabetes mellitus and Human Immunodeficiency Virus (HIV) infection, and by the use of broad-spectrum antibiotics, among others [16]. Additionally, as they are one of the largest acid producers in the oral cavity, Candida fungi can also be at the origin of dental caries through a localized infectious process [17,18,19].
Once the establishment of pathogenic oral biofilms occurs, the risk of the occurrence of systemic infections increases, as does the resistance of these infections to conventional antimicrobial therapies [20]. Currently, the treatment of Candida infections in the oral cavity is mostly done using broad-spectrum antimicrobials, however, conventional biocidal agents can cause substantial side effects if administered in high concentrations, including vomiting, diarrhea, mucosal desquamation, tooth discoloration, etc. [11,19]. Given the harmful effects of traditional antimicrobial agents, and the increasing microbial resistance to them, natural plant products have been pointed out as a safe and efficient alternative for the treatment of Candida infections in the oral cavity since, together with their anti-inflammatory, antioxidant, and analgesic properties, they also exert antimicrobial and antibiofilm effects over Candida spp [21].

2. The Bioactive Compounds of Plants

Folk knowledge about the medicinal use of plants has been transmitted for centuries [22]. In recent years, much of the ethnopharmaceutical research has been focused on more specific approaches in order to evaluate and understand the biological and pharmaceutical effects of medicinal and aromatic plants [22]. Plants are rich in a wide variety of secondary metabolites which play an important role in the defense against numerous pathogens. These molecules are also involved in adaptation to biotic and abiotic stresses, protection against ultraviolet radiation, oxidation of molecules, nutritional and water stresses, while performing functions at the tissue level structure, being able to add flavor and color to plant products [23].
Presently, about 200,000 different plant secondary metabolites have been isolated and identified [24]. They can be classified based on their chemical structures and/or biosynthetic pathways [25]. A simple classification includes three main groups: terpenoids (polymeric isoprene derivatives and biosynthesized from acetate via the mevalonic acid pathway), phenolics (biosynthesized from shikimate pathways, containing one or more hydroxylated aromatic ring), and alkaloids (nonprotein nitrogen-containing compounds, biosynthesized from amino acids, such as tyrosine) [26]. Terpenoids, the condensation products of C5 isoprene units, are the main components of plant volatiles and essential oils [27]. They present many important properties, including anti-insect, antimicrobial, antiviral, and antiherbivore properties [28]. Phenolic compounds are widely found in fruits, seeds, leaves, roots, and stems, and are known for their strong antioxidant ability and their anticancer, anti-inflammatory, hypolipidemic, and hypoglycemic properties [29,30]. They have at least one aromatic ring with one or more hydroxyl groups attached, ranging from low molecular weight molecules to large and complex ones [31]. Alkaloids are usually cyclic organic compounds that contain at least one nitrogen atom in an amine-type structure [32]. These compounds are known to possess varied biological activities such as antimicrobial and antimalarial properties, among others [33].
Many studies have been published regarding bioactive properties such as antioxidant [34,35], antitumoral [31,36], analgesic/anti-inflammatory [29,37], immunostimulant [38], antiseptic, and antimicrobial [39,40,41]. The antimicrobial and/or antibiofilm activity linked with some of these compounds is closely related to their ability to inhibit the synthesis of nucleic acids, disrupt the plasma membrane, inhibit efflux pumps, elicit mitochondrial disfunction, impair cell division and/or growth, and impair cell-wall formation, as shown in Figure 1 [42,43].
Figure 1. Mechanisms of action of phytocompounds against Candida spp. (Created with
Given their strong bioactive potential, various types of phytocompounds are currently used in a wide range of fields such as food, pharmaceuticals, biomaterials, and environmental purification [44]. Regarding the ability of these compounds as antimicrobials, multiple studies have been conducted to determine their capability to fight oral infections caused by opportunistic pathogens such as Candida species [45,46,47,48]. The increased virulence of some Candida species such as Candida albicans is largely related to their ability to form biofilms which, as mentioned before, makes oral infections caused by these microorganisms very difficult to treat [49]. Taking this information into account, the use of plant-derived products to fight oral pathologies caused by Candida appears as an alternative to conventional antifungal therapy. In oral care, the use of natural products to prevent candidiasis is receiving much attention and many studies have reported the effects of medicinal plant extracts on the inhibition of oral pathogen growth and inhibition of surfaces adhesion to surfaces [50]. Some of the most prescribed antimycotic agents that are currently used target the synthesis of fungal cell membrane components that are not found in human cells, such as ergosterol [51]. However, there are few available antifungal compounds that show low levels of cytotoxicity, given the similarities between human and fungal cells, making it urgent to search for and identify new molecules capable of disrupting biofilms formed by Candida spp. and increase the arsenal of antifungal agents [52,53]. Knowing this, screening plants as potential sources of molecules with antifungal and/or antibiofilm properties can be considered an excellent approach to combat the formation of Candida spp. oral biofilms and the establishment of infections [54].

3. Plant Extracts against Oral Biofilm Formed by Candida spp.

Most of the available antifungals are either ineffective against Candida biofilms or exhibit activity at very high concentrations [70]. Concerning microbial resistance, pharmacotherapy has reached its limit, threatening the effective prevention and treatment of an ever-increasing range of infections. These limitations have led to the search for novel molecules with antibiofilm potential. Plants are rich sources of bioactive molecules exhibiting various biological and pharmaceutical properties. Therefore, in recent years, new clinical approaches using natural phytocompounds have been the subject of several types of research, considering the composition of natural plant products in molecules with antimicrobial and/or antibiofilm potential. Table 1 presents some of the plant species whose extracts hold compounds with antifungal/antibiofilm activity against Candida spp. Moreover, extracts able to inhibit biofilm formation and/or eradication in more than 99%, at concentrations ≤ 1 mg∙mL−1, were chosen for discussion.
Allium sativum L. (Amaryllidaceae) is an aromatic herbaceous annual plant, one of the oldest authenticated and most important herbs that have been used since ancient times in traditional medicine. It is one of the most described plant species with proven antifungal, antimicrobial, anti-aging, as well as anticancer properties, which have been confirmed by epidemiological data from human clinical studies [71]. This specie and its active components have been also reported to reduce the risk of diabetes and cardiovascular diseases [72,73]. A. sativum antibiofilm properties against oral cavity yeast were studied by Fahim et al. [74] who demonstrated that, for a concentration of 8.00 µg∙mL−1, A. sativum L. essential oil presented > 99.9% of growth reduction on biofilm of C. albicans ATCC 14053. The ability of this essential oil to inhibit biofilm formation seems to be correlated with its phenolic profile, with allicin, alliin and ajoene being the major compounds found in it [75].
Essential oils from some plants have shown high antifungal and/or antibiofilm activity against Candida species. An example of this are the species of Cinnamomum cassia (L.) J. Presl, Cinnamomum zeylanicum Blume, Cymbopogon citratus (DC.) Stapf, Cymbopogon nardus L. Rendle, and Cymbopogon winterianus Jowitt.
C. cassia (L.) J.Presl (Lauraceae), also known as “Chinese cinnamon,” is a well-known aromatic plant that has been widely cultivated and utilized to treat diabetes, ovarian cysts, stomach spasms, kidney disorders, high blood pressure, and menstrual disorders [76], and presents antimicrobial, antioxidant and antifungal properties [77]. C. zeylanicum Blume (Lauraceae) is an ever-green perennial plant that is used as a culinary herb [78]. This species presents several pharmacological properties such as antimicrobial, antioxidant, antifungal, and anticancer [79]. When it comes to oral health, a study performed by Almeida et al. [80] demonstrated that C. cassia essential oil, at a concentration of 1.00 mg∙mL−1, exerts more than 99.9% reduction in oral biofilm formation caused by C. albicans ATCC 90028, while C. zeylanicum, at a concentration of 1.6 µg∙mL−1, leads to more than 99.75% reduction in oral biofilm formation caused by C. albicans ATCC 10231. The high percentage of biofilm reduction shown by these two plants is attributed to the major phytocompound found in both species, the cinnamaldehyde. Cinnamaldehyde is a phenylpropanoid that may act on the cell membrane, likely binding to enzymes involved in the formation of the cytoplasmic membrane in fungal cells [81].
C. citratus (DC.) Stapf (Poaceae), commonly known as lemongrass, is an aromatic plant widely distributed around the world. It is used as a food flavouring, and is commonly consumed in teas and soups, but it may also be served with poultry, fish, beef, and seafood. Lemongrass essential oil exhibits a number of biological activities, including antioxidant [82], anti-inflammatory [83], antimicrobial [84], antifungal, and antibiofilm properties [85]. Almeida et al. [80] used the essential oil from C. citratus as an antifungal agent against C. albicans ATCC 10231 biofilms, and reported that, at the concentration of 6.4 µg∙mL−1, this essential oil was able to reduce the number of viable cells present in the biofilm by 99.79%. In this case, citral and neral were two of the main compounds found, which are known to hold antifungal properties [86,87].
C. nardus L. (Poaceae), popularly known as citronella, is a grass cultivated in subtropical and tropical regions of Asia, Africa, and America, including Brazil [88], The essential oil extracted from its leaves is commonly used in perfumes, the production of cosmetics, and as an insect repellent. Several studies have demonstrated the antiviral [89], antibacterial [90], and antifungal activities [91] of this oil. C. winterianus Jowitt (Poaceae) is an important aromatic plant cultivated in India and Brazil. In folk medicine, it is used for the treatment of anxiety, as a sedative, and for pain disorders [92]. Some studies demonstrated that the plant has anticonvulsant effects [93], anti-larvicidal effects against Aedes aegypti [94], and antibacterial and antifungal effects, including anti-Candida action [95]. The essential oils extracted from C. nardus L. and C. winterianus Jowitt species showed, in different studies, to be highly effective in combating C. albicans oral biofilms. C. nardus showed, at a concentration of 32.0 µg∙mL−1, an adherence inhibition of C. albicans ATCC 76645 higher than 99.0%, [68] and the application of C. winterianus essential oil, at a concentration of 1.00 mg∙mL−1, led to a reduction of C. albicans ATCC 90028 oral biofilm formation by more than 99.0%. In both species, the authors attributed the antibiofilm potential to the main compound identified in these species, namely citronellal. Citronellal is known to affect C. albicans cell growth by interfering with cell-cycle progression through the arrest of cells in S phase and affecting membrane integrity [96].
Solidago virgaurea L. (Asteraceae), commonly known as goldenrod, is a medicinal plant that is common throughout the world. In the literature, this plant is described as possessing a variety of medicinal properties such as antioxidant, anti-inflammatory, analgesic, spasmolytic, antihypertensive, antibacterial, antifungal and antitumor, among others [97]. Chevalier et al. [98] evaluated the effect of the extracts from two S. virgaurea subspecies, S. virgaurea subsp. alpestris and S. virgaurea subsp. virgaurea, on C. albicans oral biofilm growth. The results obtained showed that, at an extract concentration of 250 µg∙mL−1, S. virgaurea subsp. alpestris inhibition of oral biofilms from C. albicans IM003 was higher than 99.5%, and that S. virgaurea subsp. virgaurea inhibited the oral biofilm formation by C. albicans IM001 by more than 99.2%. Regarding the chemical composition of this plant, the compounds usually found in S. virgaurea are saponins, which have been attributed to the ability to inhibit the transition from yeast to hyphal growth [98]. This attribution seems reasonable considering the inherent surfactant properties of saponins, as well as their iron chelator qualities, iron being necessary for the growth and development of Candida spp. [99].
Table 1. Medicinal plants with antimicrobial/antibiofilm activity against oral Candida spp. and the respective bioactive compounds present in their extracts.
Plant Name Plant Extract Compound Microorganism Results   References
Antimicrobial Activity Antibiofilm Activity
Allium sativum L. Essential oil (bulbs) Allicin, alliin, ajoene [75] C. albicans ATCC 14053 MIC 8.0 μg∙mL−1 >99.9% reduction 8.00 μg∙mL−1 [74]
IZD 19.0 mm (50.0 μg∙mL−1)
Aloysia gratissima (Aff & Hook) Tronc. Essential oil (leaves) (E)-pinocamphone,
β-pinene, guaiol
C. albicans CBS 562 MIC 0.015 mg∙mL−1 12.3% inhibition 1.00 mg∙mL−1 [64]
MFC 0.062 mg∙mL−1
Artemisia judaica L. Essential oil (aerial plant parts) Piperitone, camphor, ethyl cinnamate, chrysanthenone C. albicans ATCC 10231 MIC 1.25 μg∙mL−1 50.0% reduction 2.5 μg∙mL−1 [100]
Brucea javanica (L.) Merr. Aqeuous extract (seeds) Quassinoids,
C. albicans ATCC 14053 - 94.5% CSH reduction
79.7% adherence reduction
6.00 mg∙mL−1 [101]
C. dubliniensis ATCC MYA-2975 90.4% CSH reduction
27.9% adherence reduction
C. glabrata ATCC 90030 84.8% CSH reduction
76.8% adherence reduction
C. krusei ATCC 14243 97.0% CSH reduction
67.6% adherence reduction
C. lusitaniae ATCC 64125 91.1% CSH reduction
89.0% adherence reduction
C. parapsilosis ATCC 22019 98.8% CSH reduction
49.0% adherence reduction
C. tropicalis ATCC 13803 88.4% CSH reduction
89.9% adherence reduction
Cassia spectabilis DC. Methanol extract (leaves) (+)-spectaline; (−)-iso-6-cassine [102] C. albicans 1 (CI) MIC
6.25 mg∙mL−1
20 mm (100 mg∙mL−1)
97% inhibition 6.25 mg∙mL−1 [103]
C. albicans 2 (CI) MIC
6.25 mg∙mL−1
21 mm (100 mg∙mL−1)
C. albicans 3 (CI) MIC
6.25 mg∙mL−1
23 mm (100 mg∙mL−1)
Chenopodium ambrosioides L. Aqueous extract (leaves) Kaempferol, quercetin C. albicans ATCC 90028 MIC 0.250 mg∙mL−1 >99.0% reduction 1.25 mg∙mL−1 [104]
MFC 0.250 mg∙mL−1
Cinnamomum cassia L. J.Presl Essential oil (leaves, bark, stalk) Cinnamaldehyde, benzyl benzoate, α-pinene C. albicans ATCC 90028 MIC 65.5 µg∙mL−1 >99.9% reduction 1.00 mg∙mL−1 [80]
Cinnamomum verum J.Presl Essential oil (leaves) Eugenol, benzyl benzoate, trans-caryophyllene, acetyle eugenol, linalool C. albicans ATCC MYA-2876 MIC 1.0 mg∙mL−1 50% reduction 0.15 mg∙mL−1 [105]
50% inhibition 1.0 mg∙mL−1
C. tropicalis ATCC 750 50% reduction 0.35 mg∙mL−1
50% inhibition >2.0 mg∙mL−1
C. dubliniensis ATCC MYA-646 50% reduction 0.2 mg∙mL−1
50% inhibition 0.2 mg∙mL−1
Cinnamomum zeylanicum Blume Essential oil (leaves) Cinnamaldehyde, cinnamyl acetate, cinnamyl benzoate [79] C. albicans ATCC 10231 MIC 0.1 µg∙mL−1 99.75% reduction 1.6 µg∙mL−1 [106]
MFC 0.4 µg∙mL−1
IZD 42.5 mm (50 µg∙mL−1)
Coriandrum sativum L. Essential oil (leaves) Decanal, trans-2-decenal, 2-decen-1-ol, cyclodecane, cis-2-dodecenal C. albicans CBS 562 MIC 15.6 µg∙mL−1 53.43% inhibition 62.50 µg∙mL−1 [107]
MFC 31.2 µg∙mL−1
C. tropicalis CBS 94 MIC 31.2 µg∙mL−1 89.76% inhibition 125 µg∙mL−1
MFC 62.5 µg∙mL−1
C. krusei CBS 573 MIC 15.6 µg∙mL−1 42.13% inhibition 15.62 µg∙mL−1
MFC 31.2 µg∙mL−1
C. dubliniensis CBS 7987 MIC 31.2 µg∙mL−1 61.51% inhibition 62.50 µg∙mL−1
MFC 62.5 µg∙mL−1
C. rugosa CBS 12 MIC 15.6 µg∙mL−1 68.03% inhibition 62.50 µg∙mL−1
MFC 31.2 µg∙mL−1
Croton urucurana Baill. Methanol extract (stems) (epi)-catechin dimer I [108] C. albicans ATCC 10231 - 46.0% inhibition 0.500 mg∙mL−1 [109]
Cymbopogon citratus
(DC.) Stapf
Essential oil (leaves) Citral, neral, β-myrcene, geraniol [110] C. albicans ATCC 10231 MIC 0.1 µL∙mL−1 99.79% reduction 6.4 µL∙mL−1 [106]
MFC 0.4 µL∙mL−1
IZD 18.2 mm (5% v.v−1)
Ethanol extract (leaves) Citral, geraniol, neral, camphene, limonene [111] C. albicans ATCC 18804 MIC 0.625 mg∙mL−1 >99.9% inhibition 3.13 mg∙mL−1 [112]
MFC 2.50 mg∙mL−1 94.0% reduction 6.25 mg∙mL−1
Cymbopogon nardus L. Rendle Essential oil (leaves) Citronellal, citronellol, geraniol C. albicans ATCC 76645 MIC 32.0 µg∙mL−1 >99.0% inhibition 32.0 µg∙mL−1 [113]
Cymbopogon winterianus Jowitt Essential oil (leaves) Citronellal, citronellol, geraniol C. albicans ATCC 90028 MIC 250 µg∙mL−1 >99.0% reduction 1.00 mg∙mL−1 [80]
Cyperus articulatus L. Essential oil (bulbs) α-pinene, mustakone, α-bulnesene C. albicans CBS 562 MIC 0.125 mg∙mL−1 28.1% inhibition 1.00 mg∙mL−1 [112]
MFC 0.500 mg∙mL−1
Eucalyptus globulus Labill. Essential oil (leaves) Hyperoside, quercitrin, myricetin [114] C. albicans ATCC 14053 MFC 0.219 mg∙mL−1 86% reduction 22.5 mg∙mL−1 [115]
C. tropicalis ATCC 66029 0.885 mg∙mL−1 85% reduction
C. glabrata ATCC 66032 0.219 mg∙mL−1 85.2% reduction
Houttuynia cordata Thunb Ethanol extract (leaves) Aldehydes C. albicans CAD1 MFC >2.17 mg∙mL−1 70.0% reduction 1.00% (v/v) [116]
Lippia sidoides Cham. Essential oil (leaves) Thymol, p-cymene, α-caryophyllene C. albicans CBS 562 MIC 0.250 mg∙mL−1 16.5% inhibition 1.00 mg∙mL−1 [117]
MFC 0.500 mg∙mL−1
Melaleuca alternifolia (Maiden & Betche) Cheel Essential oil (leaves) Terpinen-4-ol, γ-terpinene, p-cymene, α-terpinene,1,8-cineole, α-terpineol, α-pinene C. albicans ATCC 18804 MIC 1.95 mg∙mL−1 MBEC 125 mg∙mL−1 [118]
Essential oil (leaves) Terpinen-4-ol, γ-terpinene, α-terpinene, terpinolene, 1,8-cineole C. albicans ATCC 10231 MIC 3.40 mg∙mL−1 131% adherence reduction 0.75% (v/v) [119]
C. albicans SC5314 MIC 0.84 mg∙mL−1 76.0% adherence reduction
Mikania glomerata Spreng Essential oil (leaves) Germacrene D, α-caryophyllene, bicyclogermacrene C. albicans CBS 562 MIC 0.250 mg∙mL−1 22.7% inhibition 1.00 mg∙mL−1 [117]
MFC 0.250 mg∙mL−1
Piper betle L. Aqueous extract (leaves) Hydroxychavicol, cinnamoyl derivatives, luteolin, apigenin [120] C. albicans ATCC 14053 - 38.6% CSH reduction
61.4% adherence reduction
6.00 mg∙mL−1 [101]
C. dubliniensis ATCC MYA-2975 78.3% CSH reduction
21.4% adherence reduction
C. glabrata ATCC 90030 71.4% CSH reduction
12.4% adherence reduction
C. krusei ATCC 14243 31.6% CSH reduction
56.4% adherence reduction
C. lusitaniae ATCC 64125 67.5% CSH reduction
47.6% adherence reduction
C. parapsilosis ATCC 22019 48.1% CSH reduction
46.5% adherence reduction
C. tropicalis ATCC 13803 29.7% CSH reduction
86.9% adherence reduction
Rosmarinus officinalis L. Liposoluble extract (leaves) Carnosic acid, carnosol [121] C. albicans ATCC 18804 MIC 0.78 mg∙mL−1 99.9% reduction 200 mg∙mL−1 [122]
MMC 3.13 mg∙mL−1
Satureja hortensis L. Essential oil (leaves and flowers) Thymol, λ-terpinene, carvacrol, p-cymene C. albicans F81 (CI) MIC
300 µg∙mL−1
400 µg∙mL−1
91.0% inhibition
91.0% reduction
4.80 mg∙mL−1 [123]
C. albicans F94 (CI) 200 µg∙mL−1
300 µg∙mL−1
90.0% inhibition
80.0% reduction
C. albicans F87 (CI) 300 µg∙mL−1
400 µg∙mL−1
86.0% inhibition
76.0% reduction
C. albicans F49 (CI) 400 µg∙mL−1
600 µg∙mL−1
92.0% inhibition
92.0% reduction
C. albicans F82 (CI) 400 µg∙mL−1
600 µg∙mL−1
89.0% inhibition
89.0% reduction
C. albicans F95 (CI) 400 µg∙mL−1 81.0% inhibition
81.0% reduction
C. albicans F92 (CI) 300 µg∙mL−1
600 µg∙mL−1
90.0% inhibition
90.0% reduction
C. albicans F60 (CI) 400 µg∙mL−1
600 µg∙mL−1
80.0% inhibition
80.0% reduction
C. albicans F86 (CI) 200 µg∙mL−1
300 µg∙mL−1
87.0% inhibition
87.0% reduction
C. albicans F91 (CI) 300 µg∙mL−1
400 µg∙mL−1
83.0% inhibition
83.0% reduction
C. albicans F69 (CI) 200 µg∙mL−1
300 µg∙mL−1
91.0% inhibition
80.0% reduction
C. albicans F1 (CI) 87.0% inhibition
79.0% reduction
C. albicans F34 (CI) 86.0% inhibition
91.0% reduction
C. albicans F19 (CI) 90.0% inhibition
85.0% reduction
C. albicans F78 (CI) 400 µg∙mL−1
600 µg∙mL−1
84.0% inhibition
84.0% reduction
Schinus terebinthifolia
Methanol extract (leaves) Phenolic compounds, anthraquinones, terpenoids, alkaloids C. albicans ATCC 10231 - 47.0% inhibition 0.007 mg∙mL−1 [109]
Solidago virgaurea subsp. alpestris Waldst. & Kit. ex Willd. Aqueous extract (aerial plant parts) Saponins C. albicans ATCC 10231 NA (IZD) 95.9% inhibition
92.4% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM001 (CI) 96.0% inhibition
82.2% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM003 (CI) 99.5% inhibition
76.3% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM007 (CI) 95.1% inhibition
91.9% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
Solidago virgaurea L. subsp. virgaurea. Aqueous extract (aerial plant parts) Saponins C. albicans ATCC 10231 NA (IZD) 98.4% inhibition
77.9% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM001 (CI) 99.2% inhibition
91.1% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM003 (CI) 97.3% inhibition
79.2% reduction
0.250 mg∙mL−1
0.750 mg∙mL−1
C. albicans IM007 (CI) 96.5% inhibition 90.9%
0.250 mg∙mL−1
0.750 mg∙mL−1
Terminalia catappa
Ethanol extract (leaves) Caffeic acid, quercitrin, kaempferol, gallic acid, chlorogenic acid, isoquercitrin [124] C. albicans ATCC 90028 MIC
6.25 mg∙mL−1
12.5 mg∙mL−1
>98.0% reduction 62.5 mg∙mL−1 [125]
n-butanol fraction from ethanol extract (leaves) C. albicans ATCC 90028 MIC
250 μg∙mL−1 >99.5% reduction 2.50 mg∙mL−1 [126]
C. glabrata ATCC 2001 MIC
250 μg∙mL−1 >99.0% reduction 2.50 mg∙mL−1
Trachyspermum ammi (L.) Sprague Aromatic water (aerial plant parts) Thymol, carvacrol, carvotanacetone C. albicans CBS1905 - - 95.2% inhibition 0.5% (v/v) [127]
Zataria multiflora Boiss. Aqueous extract (whole plant) Thymol, hydroxyl benzoic acid, and cymene [128] C. albicans PTCC-5027 MIC 1.50 mg∙mL−1 87% reduction 25 mg∙mL−1 [129]
Ethanolic extract (whole plant) MIC 0.84 mg∙mL−1 97% reduction

This entry is adapted from 10.3390/antibiotics10091142

This entry is offline, you can click here to edit this entry!